Last mentioned: Mar 22, 2026
The Regulatory Gap
Widespread adoption of AI by patients and doctors occurs ahead of formal FDA approval or clinical guidelines.
The Regulatory Gap
Widespread clinical use of generative AI occurs despite a lack of formal FDA approval or institutional oversight.
The LLM Explosion
Launch of ChatGPT and Claude brings interactive AI to the general public and clinicians' smartphones.
The LLM Breakthrough
Launch of ChatGPT and Claude triggers exponential growth in interactive, human-like AI accessibility.
Bioethicist Dr. John Lantos identifies a generational shift in healthcare AI, moving from specialized diagnostic tools to ubiquitous, interactive large language models. This transition is challenging the traditional authority of physicians as unregulated tools like ChatGPT and Claude become primary health resources for patients.
The rapid proliferation of large language models (LLMs) like ChatGPT and Claude is fundamentally altering the physician-patient dynamic, moving beyond traditional clinical decision support into unregulated, interactive medical consultation. Bioethicist Dr. John Lantos warns that while AI has assisted doctors for decades, the current democratization of these tools via smartphones creates a regulatory vacuum that challenges the traditional authority of medical professionals.
The integration of large language models like ChatGPT and Claude into clinical settings is fundamentally altering the traditional physician-patient relationship. Bioethicist Dr. John Lantos warns that the transition from 'invisible' diagnostic AI to 'visible' interactive AI is eroding the historical authority of doctors in a regulatory vacuum.